Correction to: Scientific Reports https://doi.org/10.1038/s41598-023-36954-z, published online 17 June 2023
The original version of this Article contained an error in the spelling of the author Rainer Böger which was incorrectly given as Rainer Böeger.
The original Article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Sozio, E., Hannemann, J., Fabris, M. et al. Author Correction: The role of asymmetric dimethylarginine (ADMA) in COVID-19: association with respiratory failure and predictive role for outcome. Sci Rep 13, 10427 (2023). https://doi.org/10.1038/s41598-023-37582-3
Published:
Version of record:
DOI: https://doi.org/10.1038/s41598-023-37582-3
